NASDAQ:ACERAcer Therapeutics Stock Price, Forecast & News

Acer Therapeutics' stock was trading at $3.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ACER stock has decreased by 7.7% and is now trading at $3.12. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acer Therapeutics in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Acer Therapeutics.

Acer Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Acer Therapeutics.

Acer Therapeutics Inc (NASDAQ:ACER) issued its earnings results on Thursday, May, 14th. The biopharmaceutical company reported ($0.49) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.40) by $0.09. View Acer Therapeutics' earnings history.

4 Wall Street analysts have issued 12 month price objectives for Acer Therapeutics' shares. Their forecasts range from $10.00 to $10.00. On average, they expect Acer Therapeutics' share price to reach $10.00 in the next year. This suggests a possible upside of 220.5% from the stock's current price. View analysts' price targets for Acer Therapeutics.

News coverage about ACER stock has been trending negative this week, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Acer Therapeutics earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave press coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Acer Therapeutics.

Acer Therapeutics saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 578,500 shares, an increase of 8.6% from the June 15th total of 532,700 shares. Based on an average daily trading volume, of 208,000 shares, the days-to-cover ratio is currently 2.8 days. Currently, 11.3% of the shares of the stock are sold short. View Acer Therapeutics' Current Options Chain.

Some companies that are related to Acer Therapeutics include Bellerophon Therapeutics (BLPH), ESSA Pharma (EPIX), PhaseBio Pharmaceuticals (PHAS), Sierra Oncology (SRRA), Inflarx (IFRX), Genprex (GNPX), TFF Pharmaceuticals (TFFP), Catabasis Pharmaceuticals (CATB), Gemphire Therapeutics (GEMP), Aldeyra Therapeutics (ALDX), Theratechnologies (THERF), OASMIA PHARMACE/ADR (OASM), Leap Therapeutics (LPTX), Eton Pharmaceuticals (ETON) and Conatus Pharmaceuticals (CNAT). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Acer Therapeutics investors own include Sarepta Therapeutics (SRPT), Amarin (AMRN), Anavex Life Sciences (AVXL), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Novavax (NVAX), Synergy Pharmaceuticals (SGYP), Advanced Micro Devices (AMD), Arena Pharmaceuticals (ARNA) and Crispr Therapeutics (CRSP).

Acer Therapeutics trades on the NASDAQ under the ticker symbol "ACER."

Shares of ACER can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACER stock can currently be purchased for approximately $3.12.

Acer Therapeutics has a market capitalization of $31.98 million. The biopharmaceutical company earns $-29,420,000.00 in net income (profit) each year or ($2.91) on an earnings per share basis. Acer Therapeutics employs 23 workers across the globe.

The official website for Acer Therapeutics is www.acertx.com.

Acer Therapeutics' mailing address is 300 WASHINGTON STREET SUITE 351, NEWTON MA, 02458. The biopharmaceutical company can be reached via phone at 844-902-6100 or via email at [email protected]